Literature DB >> 10073645

Early expression of marker genes in the rabbit medial collateral and anterior cruciate ligaments: the use of different viral vectors and the effects of injury.

K A Hildebrand1, M Deie, C R Allen, D W Smith, H I Georgescu, C H Evans, P D Robbins, S L Woo.   

Abstract

Gene therapy is a technique that may offer advantages over current methods of cytokine delivery to ligaments. To determine if implanted genes could be expressed in normal and injured knee ligaments, the medial collateral ligament and anterior cruciate ligament were studied in 18 rabbits. A retroviral ex vivo technique using allograft medial collateral ligament and anterior cruciate ligament fibroblasts and an adenoviral in vivo technique were compared as methods for delivering the LacZ marker gene to knee ligaments. Bilateral knee surgeries were performed, and the rabbits were equally divided into three groups. Group 1 received the retrovirus and the medial collateral ligament was ruptured, Group 2 received the adenovirus and the medial collateral ligament was ruptured, and Group 3 received the adenovirus and the medial collateral ligament was not injured. The anterior cruciate ligament was not injured in any group. The medial collateral and anterior cruciate ligaments of the right knees received 10(6) allografted, transduced ligament fibroblasts or 10(9) adenovirus particles, whereas the ligaments of the left knee received a similar volume of saline solution only. Equal numbers of rabbits were killed at 10 days, 3 weeks, and 6 weeks following the procedure. Ligament samples were stained with X-gal to detect the expression of the LacZ gene product, beta-galactosidase. LacZ gene expression was evident in ruptured and uninjured medial collateral ligaments as well as in the anterior cruciate ligament. The expression lasted between 10 days and 3 weeks in the medial collateral and anterior cruciate ligaments with use of the retrovirus and between 3 and 6 weeks in the medial collateral ligament and at least 6 weeks in the anterior cruciate ligament with the adenovirus. The length of gene expression in the ruptured and uninjured medial collateral ligaments did not differ. These preliminary studies indicate that gene transfer to normal and injured knee ligaments is possible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073645     DOI: 10.1002/jor.1100170107

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  12 in total

Review 1.  Cytokines and the role they play in the healing of ligaments and tendons.

Authors:  C H Evans
Journal:  Sports Med       Date:  1999-08       Impact factor: 11.136

2.  Gene transfer to the tendon-bone insertion site.

Authors:  Christian Lattermann; Boris A Zelle; Janey D Whalen; Axel W A Baltzer; Paul D Robbins; Christopher Niyibizi; Christopher H Evans; Freddie H Fu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-03-09       Impact factor: 4.342

Review 3.  Tendon and ligament engineering in the adult organism: mesenchymal stem cells and gene-therapeutic approaches.

Authors:  Andrea Hoffmann; Gerhard Gross
Journal:  Int Orthop       Date:  2007-07-19       Impact factor: 3.075

4.  IN VITRO TRANSPLANTATION OF GENETICALLY MODIFIED CELLS TO THE TENDON SURFACE.

Authors:  Paulus J J Couvreur; Chunfeng Zhao; Stephen Murphy; Peter C Amadio
Journal:  J Musculoskelet Res       Date:  2008

5.  Autologous transplantation of culture-born myofibroblasts into intact and injured rabbit ligaments.

Authors:  Thomas Laumonier; Marlene Michel; Giulio Gabbiani; Pierre Hoffmeyer; Marie-Luce Bochaton-Piallat; Jacques Menetrey
Journal:  Int Orthop       Date:  2012-03-30       Impact factor: 3.075

Review 6.  Orthopedic gene therapy in 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

Review 7.  Clinical potential and challenges of using genetically modified cells for articular cartilage repair.

Authors:  Henning Madry; Magali Cucchiarini
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

8.  Tissue engineering strategies in ligament regeneration.

Authors:  Caglar Yilgor; Pinar Yilgor Huri; Gazi Huri
Journal:  Stem Cells Int       Date:  2011-12-25       Impact factor: 5.443

Review 9.  Gene Therapy for Cartilage Repair.

Authors:  Henning Madry; Patrick Orth; Magali Cucchiarini
Journal:  Cartilage       Date:  2011-07       Impact factor: 4.634

Review 10.  Biologics for tendon repair.

Authors:  Denitsa Docheva; Sebastian A Müller; Martin Majewski; Christopher H Evans
Journal:  Adv Drug Deliv Rev       Date:  2014-11-21       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.